Tag Archives: PFE

Inovio Pharmaceuticals (NYSE:INO) Loss Widens in Fiscal First Quarter – INO, MRK, PPHM, PFE

Posted on May 13, 2013 by Thomas Vedder

Inovio Pharmaceuticals Inc (NYSE:INO) on Friday announced fiscal Q1 net loss was $8.86 million or $0.06 per share, evaluated against $8.3 million or $.06 per share in previous year.

Revenue for three months period plunged to $1.5 million from $1.7 …

Posted in Healthcare, Latest Headlines, Latest Picks | Tagged INO, Inovio Pharmaceuticals, Merck, MRK, NASDAQ:PPHM, NYSE:INO, NYSE:MRK, NYSE:PFE, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM | Comments Off

Healthcare Sector News Buzz: Mylan (NASDAQ:MYL), Gilead Sciences (NASDAQ:GILD) – MYL, GILD, PFE, QCOR, BKD, AVEO

Posted on May 3, 2013 by Thomas Vedder

Investors responded positively to the healthcare stocks on Thursday. Key movement were observed in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and Brookdale Senior Living, Inc (NYSE:BKD) on percentage gainers side while AVEO Pharmaceuticals, Inc (NASDAQ:AVEO) was prominent stock on percentage decliner side.…

Posted in Healthcare, Latest Headlines | Tagged AVEO, AVEO Pharmaceuticals, BKD, Brookdale Senior Living, GILD, Gilead Sciences, MYL, Mylan, NASDAQ:AVEO, NASDAQ:GILD, NASDAQ:MYL, NASDAQ:QCOR, NYSE:BKD, NYSE:PFE, PFE, Pfizer, QCOR, Questcor Pharmaceuticals | Comments Off

Healthcare Sector Roundup: Covance (NYSE:CVD), Merck (NYSE:MRK) – CVD, MRK, PFE, AGN, ASTX, REGN

Posted on May 2, 2013 by Thomas Vedder

Healthcare sector finished lower on Tuesday’s trading session and sector tumbled -1.13%. If we consider at the best movers of the sector so Allergan, Inc (NYSE:AGN) and Astex Pharmaceuticals, Inc (NASDAQ:ASTX) were major percentage decliners while key percentage gainer was …

Posted in Healthcare, Latest Headlines | Tagged AGN, Allergan, Astex, ASTX, Covance, CVD, Merck, MRK, NASDAQ:ASTX, NASDAQ:REGN, NYSE:AGN, NYSE:CVD, NYSE:MRK, NYSE:PFE, PFE, Pfizer, Regeneron, REGN | Comments Off

Questcor Pharmaceuticals (NASDAQ:QCOR) First Quarter Profit Hikes But Misses Estimates – QCOR, PFE, TSPT, FRX

Posted on May 1, 2013 by Thomas Vedder

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) declared fiscal Q1 profit hiked from previous year, showing strong double-digit sales expansion amid contribution from acquisition of BioVectra, Inc.

Biotechnology Company announced net income was $39.06 million or $0.65 a share for fiscal Q1, over …

Posted in Healthcare, Latest Headlines | Tagged Forest Laboratories, FRX, NASDAQ:QCOR, NASDAQ:TSPT, NYSE:FRX, NYSE:PFE, PFE, Pfizer, QCOR, Questcor Pharmaceuticals, Transcept Pharmaceuticals, TSPT | Comments Off

Healthcare Sector Overview: Pfizer (NYSE:PFE), Aetna (NYSE:AET) – PFE, AET, JNJ, AMRN, DCTH, ZIOP

Posted on May 1, 2013 by Thomas Vedder

Tuesday’s trading session data confirmed that healthcare sector reacted negatively with -0.91% change. Amarin Corporation plc (ADR) (NASDAQ:AMRN) was major percentage gainer in this sector while key percentage decliners were Delcath Systems, Inc (NASDAQ:DCTH) and ZIOPHARM Oncology Inc (NASDAQ:ZIOP).

Pfizer …

Posted in Healthcare, Latest Headlines | Tagged AET, Aetna, Amarin, AMRN, DCTH, Delcath, JNJ, Johnson, NASDAQ:AMRN, NASDAQ:DCTH, NASDAQ:ZIOP, NYSE:AET, NYSE:JNJ, NYSE:PFE, PFE, Pfizer, ZIOP, ZIOPHARM Oncology | Comments Off

Key Percentage Movers Highlights: Pfizer (NYSE:PFE), Herbalife (NYSE:HLF)

Posted on April 30, 2013 by Geoff Noir

Pfizer Inc (NYSE:PFE) reported on Tuesday that its fiscal Q1 profit moved up 53 percent to $2.75 billion from $1.79 billion in previous year. EPS hiked to 38 cents from 24 cents in previous year, while adjusted earnings tumbled to …

Posted in Latest Headlines | Tagged Herbalife, HLF, NYSE:HLF, NYSE:PFE, PFE, Pfizer | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.